Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine - PubMed (original) (raw)

Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine

N Bouck et al. Mol Cell Biol. 1984 Jul.

Abstract

The permanent cell line BHK-21/cl 13 can be transformed by mutagenic carcinogens as the result of the induction of a recessive somatic mutation. Yet when these cells were treated with 5-azacytidine under conditions in which no mutants resistant to either ouabain or 6-thioguanine could be detected, they were transformed efficiently. These transformants were induced, not selected. 6-Azacytidine was ineffective at transforming BHK cells; 2'-deoxy-5-azacytidine was exceptionally effective. When tested by cell fusion, transformants induced by 5-azacytidine fell into the same complementation group as those induced by highly mutagenic carcinogens, but they were phenotypically distinct in that they were unstable during prolonged passage and rarely displayed the temperature-limited phenotypes so common among BHK transformants induced by strongly mutagenic carcinogens. These results raise the possibility that a cell can be induced by either genetic or epigenetic means to traverse the same single step in carcinogenesis.

PubMed Disclaimer

Cited by

Differential activation of the hprt gene on the inactive X chromosome in primary and transformed Chinese hamster cells.
Grant SG, Worton RG. Grant SG, et al. Mol Cell Biol. 1989 Apr;9(4):1635-41. doi: 10.1128/mcb.9.4.1635-1641.1989. Mol Cell Biol. 1989. PMID: 2471066 Free PMC article.
Sudden outbreak of a leukemia-like lesion in female CBA mice after repeated injections of 5-azacytidine.
Luz A, Murray AB. Luz A, et al. J Cancer Res Clin Oncol. 1988;114(5):525-7. doi: 10.1007/BF00391506. J Cancer Res Clin Oncol. 1988. PMID: 2460465
Capture and characterization of 5-aza-2'-deoxycytidine-treated C3H/10T1/2 cells prior to transformation.
Rainier S, Feinberg AP. Rainier S, et al. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6384-8. doi: 10.1073/pnas.85.17.6384. Proc Natl Acad Sci U S A. 1988. PMID: 2457912 Free PMC article.
Carcinogenicity and haemoglobin synthesis induction by cytidine analogues.
Carr BI, Rahbar S, Asmeron Y, Riggs A, Winberg CD. Carr BI, et al. Br J Cancer. 1988 Apr;57(4):395-402. doi: 10.1038/bjc.1988.89. Br J Cancer. 1988. PMID: 2455532 Free PMC article.

References

1. Mol Cell Biol. 1982 Jun;2(6):708-14 - PubMed
1. Mol Cell Biol. 1982 Dec;2(12):1574-80 - PubMed
1. J Virol. 1968 Oct;2(10):1228-9 - PubMed
1. Cancer Res. 1973 Dec;33(12):3069-85 - PubMed
1. Proc Natl Acad Sci U S A. 1976 Mar;73(3):950-4 - PubMed

Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine - PubMed (original) (raw)